Efficacy of mirtazapine for prevention of depressive relapse: A placebo-controlled double-blind trial of recently remitted high-risk patients

Journal of Clinical Psychiatry

Volumn 62, Issue 10, 2001, Pages 782-788

  Thase, M E ^a   Nierenberg, A A ^a   Keller, M B ^a   Panagides, J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MIRTAZAPINE; PLACEBO;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 0035200581     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n1006     Document Type: Article

References (24)

1. Practice guideline for the treatment of patients with major depressive disorder
2. Relapse and recurrence of depression: An updated practical approach for prevention
3. Implications of falling to achieve successful long-term maintenance treatment of recurrent unipolar major depression
4. Continuation drug therapy for major depressive episodes: How long should it be maintained?
5. Long-term treatment of depression
6. Long-term nature of depression
7. The pharmacologic profile of mirtazapine
8. Clinical efficacy of mirtazapine: A review of meta-analyses of pooled data
9. Mirtazapine efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe depressive disorder
10. Mirtazapine versus amitriptyline in the long-term treatment of depression: A double-blind placebo-controlled study
11. A rating scale for depression
12. A structured interview guide for the Hamilton depression rating scale
13. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
14. The placebo problem remains
15. Maintenance phase efficacy of sertraline for chronic depression. A randomized controlled trial
16. Maintenance strategies for unipolar depression: An observational study of levels of treatment and recurrence
17. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder
18. Prevention of relapse in residual depression by cognitive therapy
19. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy